Lei, Q., Hou, H., Wang, F., et al. 2020. Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients. 
* https://doi.org/10.1101/2020.07.09.20149633

University of Michigan - Ann Arbor

-  Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
- SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
-  Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–[negative] implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
- Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers. 

MedRxiv Preprint Papers Related to SARS-CoV-2 Antibody Testing

Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients

Wajnberg, A., Amanat, F., Firpo, A. et al. 2020. SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months. 
* doi: https://doi.org/10.1101/2020.07.14.20151126

SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months

Tao Liu, MD1*; Sanyun Wu, MD, PhD2*; Huangheng Tao, PhD3*; Guang Zeng, MD1; Fuling Zhou, MD2 †; Fangjian Guo, MD, PhD4,5†; Xinghuan Wang, MD1†

https://www.medrxiv.org/content/10.1101/2020.06.13.20130252v1.full.pdf

Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2

Patel E, Bloch EM, Clarke W, et al. Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers. Preprint. medRxiv. 2020;2020.08.31.20184788. Published 2020 Sep 2. doi:10.1101/2020.08.31.20184788

Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers. 

Learn Before

Related